4 employees
BliNK Biomedical is specializes in the discovery and development of first or best-in-class antibody-based therapeutics.
2015
$5M
from 2 investors over 2 rounds
BliNK Biomedical raised $1.9M on July 12, 2016
Investors: Idinvest Partners
BliNK Biomedical raised $5M on December 11, 2014